Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - US
The Guardian - US
World
Anna Betts

Eli Lilly shares bought on Trump’s behalf as his policies benefited drug firm

a red banner on a building reads 'Lilly 150 years of medicine'
The entrance to the New York Stock Exchange after the opening bell on Wall Street on 11 May 2026 in New York City. Photograph: John Angelillo/UPI/Shutterstock

Hundreds of thousands of dollars were invested in Eli Lilly on Donald Trump’s behalf earlier this year, according to financial disclosures, as the US drugmaker benefited from his administration’s move to expand access to blockbuster obesity treatments.

Ethics filings revealed several thousand trades on the US president’s behalf tied to stocks and bonds in the first quarter of 2026, with a cumulative ​value of between $220m and about $750m.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.